Glycemic Control and Body Weight Reduction with Once-Weekly Semaglutide in Colombian Adults with Type 2 Diabetes: Findings from the COLIBRI Study.

Dagoberto Serpa-Díaz Carlos A Llanos-Florez Ronald Serrano Uribe Dora I Molina de Salazar Germán Camilo Giraldo-González Miguel Alberto Urina-Triana Andres F Suarez-Rodriguez María Alejandra Alzate

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2024)

Patients treated with once-weekly semaglutide experienced a clinically significant reduction in HbA1c and body weight. These results are in line with previous clinical trials.

Keyphrases

body weight
glycemic control
clinical trial
type diabetes
blood glucose
randomized controlled trial
metabolic syndrome